EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA

Yu-Tien Chang, Zhi-Jie Hong, Hsueh-Han Tsai, An-Chieh Feng, Tzu-Ya Huang, Jyh-Cherng Yu, Kuo-Feng Hsu, Chi-Cheng Huang, Wei-Zhi Lin, Chi-Ming Chu, Chia-Ming Liang, Guo-Shiou Liao

Breast Cancer · 2024

DOI: 10.1007/s12282-024-01627-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer, 2024. Verfasst von Yu-Tien Chang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, National Defense Medical Center, Taipei City, Taiwan. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer (BC) is the most common cancer in women and accounts for approximately 15% of all cancer deaths among women globally. The underlying mechanism of BC patients with small tumor size and developing distant metastasis (DM) remains elusive in clinical practices.

Methods

We integrated the gene expression of BCs from ten RNAseq datasets from Gene Expression Omnibus (GEO) database to create a genetic prediction model for distant metastasis-free survival (DMFS) in BC patients with small tumor sizes (≤ 2 cm) using weighted gene co-expression network (WGCNA) analysis and LASSO cox regression.

Results

ABHD11, DDX39A, G3BP2, GOLM1, IL1R1, MMP11, PIK3R1, SNRPB2, and VAV3 were hub metastatic genes identified by WGCNA and used to create a risk score using multivariable Cox regression. At the cut-point value of the median risk score, the high-risk score (≥ median risk score) group had a higher risk of DM than the low-risk score group in the training cohort [hazard ratio (HR) 4.51, p < 0.0001] and in the validation cohort (HR 5.48, p = 0.003). The nomogram prediction model of 3-, 5-, and 7-year DMFS shows good prediction results with C -indices of 0.72–0.76. The enriched pathways were immune regulation and cell–cell signaling. EGFR serves as the hub gene for the protein–protein interaction network of PIK3R1, IL1R1, MMP11, GOLM1, and VAV3.

Conclusion

Prognostic gene signature was predictive of DMFS for BCs with small tumor sizes. The protein–protein interaction network of PIK3R1, IL1R1, MMP11, GOLM1, and VAV3 connected by EGFR merits further experiments for elucidating the underlying mechanisms. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBiomarkers, TumorHumansFemaleReceptors, Interleukin-1 Type IProto-Oncogene Proteins c-vavMiddle AgedGene Regulatory NetworksGene Expression Regulation, NeoplasticClass Ia Phosphatidylinositol 3-KinaseGene Expression ProfilingMatrix Metalloproteinase 11PrognosisMembrane ProteinsTumor BurdenNeoplasm MetastasisProportional Hazards Models

Stichwörter der Autor:innen

Breast cancerDistant metastasis-free survivalLASSO cox regressionSmall tumor sizeWeighted gene co-expression network analysis

Substanzen

PIK3R1 protein, humanBiomarkers, TumorReceptors, Interleukin-1 Type IProto-Oncogene Proteins c-vavVAV3 protein, humanClass Ia Phosphatidylinositol 3-KinaseMMP11 protein, humanIL1R1 protein, humanMatrix Metalloproteinase 11Membrane Proteins

Autor:innen und Institutionen

  • School of Public Health, National Defense Medical Center, Taipei City, Taiwan.
  • Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Chenggong Rd., Neihu Dist., Taipei City, 114202, Taiwan.
  • Department of Surgery, Taipei Veterans General Hospital, No.201, Sec. 2, Shipai Rd., Beitou District, Taipei City, 11217, Taiwan.
  • Comprehensive Breast Health Center, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Beitou District, Taipei City, 11217, Taiwan.
  • Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, No. 17, Xuzhou Rd., Taipei City, 100, Taiwan.
  • AIoT Center, Tri-Service General Hospital, Taipei City, Taiwan.

Förderung

  • Tri-Service General Hospital

Zitieren

APA

Chang, Y. T., Hong, Z. J., Tsai, H. H., Feng, A. C., Huang, T. Y., Yu, J. C., Hsu, K. F., Huang, C. C., Lin, W. Z., Chu, C. M., Liang, C. M., & Liao, G. S. (2024). Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA. Breast Cancer. https://doi.org/10.1007/s12282-024-01627-w

Vancouver

Chang YT, Hong ZJ, Tsai HH, Feng AC, Huang TY, Yu JC, et al. Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA. Breast Cancer. 2024. doi:10.1007/s12282-024-01627-w

BibTeX
@article{Chang2024,
  author = {Chang, Yu-Tien and Hong, Zhi-Jie and Tsai, Hsueh-Han and Feng, An-Chieh and Huang, Tzu-Ya and Yu, Jyh-Cherng and Hsu, Kuo-Feng and Huang, Chi-Cheng and Lin, Wei-Zhi and Chu, Chi-Ming and Liang, Chia-Ming and Liao, Guo-Shiou},
  title = {Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA},
  journal = {Breast Cancer},
  year = {2024},
  doi = {10.1007/s12282-024-01627-w}
}
Kostenlos starten →